The aimed of this study was to determine the implication of the biochemical and the molecular mechanism and to describe the properties of an extended-spectrum β-lactamase (ESBL) CTX-M-8 which was reported for the first time in Africa. A clinical isolate of Proteus mirabilis FS6449 was isolated from a patient hospitalized at an intensive care unit of the Military Hospital in Tunisia in 2009. Antimicrobial susceptibility was determined with the disk diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guidelines and revealed that this strain was resistant to expanded-spectrum β-lactams. Analysis of P. mirabilis FS6449 by double-disk synergy test yielded a positive result suggesting the production of ESBLs. Sonicate...
The incidence of resistance by Enterobacteriaceae to β-lactam/β-lactamase inhibitors combination is ...
Introduction: The wide diffusion of extended spectrum β-lactamases ...
Introduction: The wide diffusion of extended spectrum β-lactamases ...
Objectives: The aim of this study was to characterize the different inhibitor-resistant TEM b-lactam...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
To examine the dissemination of CTX-M-type extended-spectrum beta-lactamases (ESBLs) in clinical iso...
To analyse the genotypes of clinical isolates of Extended-Spectrum-β-Lactamase-Producing (ESBL-produ...
Extended Spectrum Beta Lactamase-among Proteus mirabilis strains recorded high incidence leaving few...
CTX-M-14– and -2–like extended-spectrum β-lactamases were detected in 5 and 1 Proteus mirabilis isol...
Among 222 Proteus mirabilis clinical isolates collected from 17 hospitals in Korea in 2008, 28 (12.6...
Objectives: A study was conducted to evaluate the occurrence and characterization of extended-spec-t...
Introduction: The wide diffusion of extended spectrum β-lactamases ...
The incidence of resistance by Enterobacteriaceae to β-lactam/β-lactamase inhibitors combination is ...
Introduction: The wide diffusion of extended spectrum β-lactamases ...
Introduction: The wide diffusion of extended spectrum β-lactamases ...
Objectives: The aim of this study was to characterize the different inhibitor-resistant TEM b-lactam...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
A remarkable increase in Proteus mirabilis strains producing acquired AmpC-type β-lactamases (CBLs) ...
To examine the dissemination of CTX-M-type extended-spectrum beta-lactamases (ESBLs) in clinical iso...
To analyse the genotypes of clinical isolates of Extended-Spectrum-β-Lactamase-Producing (ESBL-produ...
Extended Spectrum Beta Lactamase-among Proteus mirabilis strains recorded high incidence leaving few...
CTX-M-14– and -2–like extended-spectrum β-lactamases were detected in 5 and 1 Proteus mirabilis isol...
Among 222 Proteus mirabilis clinical isolates collected from 17 hospitals in Korea in 2008, 28 (12.6...
Objectives: A study was conducted to evaluate the occurrence and characterization of extended-spec-t...
Introduction: The wide diffusion of extended spectrum β-lactamases ...
The incidence of resistance by Enterobacteriaceae to β-lactam/β-lactamase inhibitors combination is ...
Introduction: The wide diffusion of extended spectrum β-lactamases ...
Introduction: The wide diffusion of extended spectrum β-lactamases ...